Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
epigenome
Research
Tune’s HBV therapy hits the right notes in cells and mice
Tune Therapeutics' epigenetic editor represses HBV genes in cell lines in mice almost completely, setting the stage for clinical trials in humans.
Helen Floersh
Dec 7, 2023 2:05pm
Music to its ears: Tune bags $40M to alter gene expression
Dec 2, 2021 6:00am
Software for the DNA hardware: Chroma snags $125M for epigenome
Nov 17, 2021 6:00am
Cambridge Epigenetix lines up $88M for genetic sequencing tech
Nov 2, 2021 10:20am
Potential pain remedy emerges from 'junkyard of cancer drugs'
Oct 27, 2021 9:52am
Amping up immune cells to kill cancer
Feb 22, 2021 9:20am
